Concepedia

G C Koo

GC

26

Publications

1.7K

Citations

22

H-Index

1976

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Memorial Sloan Kettering Cancer Center

The University of Texas Southwestern Medical Center

Stanford University

Cornell University

G C Koo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

MedicineImmunologyCell BiologyImmunotherapyAutoimmunityImmune SystemNatural Killer CellsPathologyAutoimmune DiseaseCell Signaling

Publications per year

1976–1997

26

Publications

26

Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo

G C Koo, Joseph T. Blake, Althea Talento et al. · The Journal of Immunology · 1997 · 217 citations · Full text

Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity.

William E. Seaman, Marvin H. Sleisenger, E Eriksson et al. · The Journal of Immunology · 1987 · 182 citations · Full text

Adaptive Immune System, Immunology, Nk Cells +16

The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.

G C Koo, Florent Dumont, M M Tutt et al. · The Journal of Immunology · 1986 · 163 citations

Cell Therapy, Natural Killer Cells, Weekly Injections +15

Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.

John Hackett, M M Tutt, Mary F. Lipscomb et al. · The Journal of Immunology · 1986 · 121 citations · Full text

Purified Nk-1.1+ Cells, Laboratory Immunology, Lymphocyte Development +18

Antigenic profile of murine natural killer cells.

G C Koo, Janet B. Jacobson, Günter J. Hämmerling et al. · The Journal of Immunology · 1980 · 108 citations

Cancer Immunosurveillance, Allergy, Autoimmune Disease +14

Rows per page

1–5 of 26